Crossmark

Cost-effectiveness analysis of linezolid versus vancomycin in the treatment of adult hospital-acquired and ventilator-associated methicillin-resistant staphylococcus Aureus Pneumonia (a systematic review)

Crossref DOI link: https://doi.org/10.1186/s12962-026-00781-6

Published Online: 2026-08-27

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Moghadam, Efat Mohebi

Jahangiri, Reza

Hadian, Mohamad
License Information

Text and Data Mining valid from 2026-08-27

Accepted Manuscript valid from 2026-08-27
More Information

Article History

Received: 13 November 2025

Accepted: 29 May 2026

First Online: 27 August 2026

Declarations

Ethical approval: Since this study did not involve human participants and the selected sources are publicly available, ethical approval was not required.

Competing interests: The authors declare no competing interests.

Document is current

Any future updates will be listed below